MicroRNA hsa-miR-29a-3p modulates CYP2C19 in human liver cells
Dianke Yu(Qingdao University), Baitang Ning(National Center for Toxicological Research), Yongli Guo(Chinese Academy of Medical Sciences & Peking Union Medical College), Bridgett Green(National Center for Toxicological Research), William H. Tolleson(National Center for Toxicological Research), Yaqiong Jin(Hebei Medical University), Nan Mei(Jilin Agricultural University), Helen Deng(Arkansas Department of Health), Igor P. Pogribny(National Center for Toxicological Research)
Cited by 59
Related Papers
A comprehensive assessment of RNA-seq accuracy, reproducibility and information content by the Sequencing Quality Control Consortium
|Nature Biotechnology|2014|1.1k
The MicroArray Quality Control (MAQC)-II study of common practices for the development and validation of microarray-based predictive models
|Nature Biotechnology|2010|918
Involvement of microRNA-451 in resistance of the MCF-7 breast cancer cells to chemotherapeutic drug doxorubicin
|Molecular Cancer Therapeutics|2008|635
Circulating MicroRNAs, miR-21, miR-122, and miR-223, in patients with hepatocellular carcinoma or chronic hepatitis
|Molecular Carcinogenesis|2010|558
A rat RNA-Seq transcriptomic BodyMap across 11 organs and 4 developmental stages
|Nature Communications|2014|436